Pharvaris Bv Stock Market Value

PHVS Stock  USD 18.36  0.91  5.21%   
Pharvaris' market value is the price at which a share of Pharvaris trades on a public exchange. It measures the collective expectations of Pharvaris BV investors about its performance. Pharvaris is selling for under 18.36 as of the 18th of January 2025; that is 5.21 percent up since the beginning of the trading day. The stock's lowest day price was 17.33.
With this module, you can estimate the performance of a buy and hold strategy of Pharvaris BV and determine expected loss or profit from investing in Pharvaris over a given investment horizon. Check out Pharvaris Correlation, Pharvaris Volatility and Pharvaris Alpha and Beta module to complement your research on Pharvaris.
Symbol

Pharvaris BV Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharvaris. If investors know Pharvaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharvaris listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.68)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of Pharvaris BV is measured differently than its book value, which is the value of Pharvaris that is recorded on the company's balance sheet. Investors also form their own opinion of Pharvaris' value that differs from its market value or its book value, called intrinsic value, which is Pharvaris' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharvaris' market value can be influenced by many factors that don't directly affect Pharvaris' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharvaris' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharvaris is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharvaris' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pharvaris 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharvaris' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharvaris.
0.00
12/19/2024
No Change 0.00  0.0 
In 31 days
01/18/2025
0.00
If you would invest  0.00  in Pharvaris on December 19, 2024 and sell it all today you would earn a total of 0.00 from holding Pharvaris BV or generate 0.0% return on investment in Pharvaris over 30 days. Pharvaris is related to or competes with Pmv Pharmaceuticals, MediciNova, PepGen, Molecular Partners, Mineralys Therapeutics,, AN2 Therapeutics, and Monte Rosa. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapie... More

Pharvaris Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharvaris' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharvaris BV upside and downside potential and time the market with a certain degree of confidence.

Pharvaris Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharvaris' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharvaris' standard deviation. In reality, there are many statistical measures that can use Pharvaris historical prices to predict the future Pharvaris' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharvaris' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.3518.4922.63
Details
Intrinsic
Valuation
LowRealHigh
17.5621.7025.84
Details
7 Analysts
Consensus
LowTargetHigh
30.6833.7137.42
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.77-0.66-0.62
Details

Pharvaris BV Backtested Returns

Pharvaris BV maintains Sharpe Ratio (i.e., Efficiency) of -0.0607, which implies the firm had a -0.0607% return per unit of risk over the last 3 months. Pharvaris BV exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pharvaris' Risk Adjusted Performance of (0.01), variance of 17.09, and Coefficient Of Variation of (4,816) to confirm the risk estimate we provide. The company holds a Beta of 0.16, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pharvaris' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharvaris is expected to be smaller as well. At this point, Pharvaris BV has a negative expected return of -0.25%. Please make sure to check Pharvaris' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Pharvaris BV performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.27  

Weak reverse predictability

Pharvaris BV has weak reverse predictability. Overlapping area represents the amount of predictability between Pharvaris time series from 19th of December 2024 to 3rd of January 2025 and 3rd of January 2025 to 18th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharvaris BV price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Pharvaris price fluctuation can be explain by its past prices.
Correlation Coefficient-0.27
Spearman Rank Test0.14
Residual Average0.0
Price Variance1.0

Pharvaris BV lagged returns against current returns

Autocorrelation, which is Pharvaris stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharvaris' stock expected returns. We can calculate the autocorrelation of Pharvaris returns to help us make a trade decision. For example, suppose you find that Pharvaris has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Pharvaris regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharvaris stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharvaris stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharvaris stock over time.
   Current vs Lagged Prices   
       Timeline  

Pharvaris Lagged Returns

When evaluating Pharvaris' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharvaris stock have on its future price. Pharvaris autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharvaris autocorrelation shows the relationship between Pharvaris stock current value and its past values and can show if there is a momentum factor associated with investing in Pharvaris BV.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.